8 results
8-K
EX-99.1
HARP
Harpoon Therapeutics Inc
26 Jan 24
Other Events
12:00am
(%) n (%) White 76 (89.4) 18 (85.7) Asian 4 (4.7) 1 (4.8) American Indian or Alaska Native 1 (1.2) 0 Multiple 1 (1.2) 0 Other 1 (1.2) 1 (4.8) Unknown
8-K
EX-99.1
HARP
Harpoon Therapeutics Inc
23 Oct 23
Other Events
8:00am
42 (59.2%) Race n (%) White 65 (91.5%) Asian 3 (4.2%) American Indian or Alaska Native 1 (1.4%) Multiple 1 (1.4%) Unknown 1 (1.4%) # Prior Therapies
PRE 14A
HARP
Harpoon Therapeutics Inc
14 Apr 23
Preliminary proxy
4:54pm
: Gender Identity
Directors
Part II: Demographic Background
African American or Black
Alaskan Native or Native American
Asian
Hispanic or Latinx
8-K
EX-99.3
hju8ymxefocwpok07
4 Jun 21
Harpoon Therapeutics Presents Updated Interim Clinical Data for the PSMA-targeting TriTACĀ® HPN424 at the 2021 ASCO Annual Meeting
4:40pm
8-K
EX-99.2
7gf4d
9 Dec 20
Harpoon Therapeutics Reports Clinical Progress Across All Four TriTACĀ® Pipeline Development Programs
4:52pm
8-K
EX-99.2
zid6h
29 May 20
Harpoon Therapeutics Presents Interim Phase 1 Data from an Ongoing Dose
4:03pm
- Prev
- 1
- Next